Literature DB >> 18766476

Bisphosphonate-induced fractures: nature strikes back?

Per Aspenberg.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18766476     DOI： 10.1080/17453670710015427

Source DB:  PubMed          Journal:  Acta Orthop        ISSN： 1745-3674            Impact factor:   3.717


× No keyword cloud information.
  5 in total

1.  Bisphosphonate-associated femur fractures have high complication rates with operative fixation.

Authors:  Mark L Prasarn; Jaimo Ahn; David L Helfet; Joseph M Lane; Dean G Lorich
Journal:  Clin Orthop Relat Res       Date:  2012-06-06       Impact factor: 4.176

2.  Case reports: subtrochanteric femoral stress fractures after prolonged alendronate therapy.

Authors:  Katerina Cermak; Felix Shumelinsky; Jean Alexiou; Michael J Gebhart
Journal:  Clin Orthop Relat Res       Date:  2009-12-18       Impact factor: 4.176

3.  Femoral insufficiency fractures associated with prolonged bisphosphonate therapy.

Authors:  Joseph D Isaacs; Louis Shidiak; Ian A Harris; Zoltan L Szomor
Journal:  Clin Orthop Relat Res       Date:  2010-08-31       Impact factor: 4.176

4.  Atypical fracture of the ulna associated with alendronate use.

Authors:  Kristian Bjørgul; Astor Reigstad
Journal:  Acta Orthop       Date:  2011-11-09       Impact factor: 3.717

5.  Association between alendronate and atypical femur fractures: a meta-analysis.

Authors:  Lu Liu; Chunyan Li; Peng Yang; Jian Zhu; Dongmei Gan; Le Bu; Manna Zhang; Chunjun Sheng; Hong Li; Shen Qu
Journal:  Endocr Connect       Date:  2014-12-23       Impact factor: 3.335
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.